Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

Area of Science:

• Oncology
• Genomics
• Cancer Evolution

Background:

• Non-small cell lung cancer (NSCLC) has a poor prognosis, partly due to complex genomic alterations.
• Understanding the spatial and temporal genomic changes in NSCLC is crucial for improving treatment outcomes.

Purpose of the Study:

• To dissect the spatial and temporal genomic evolution of human NSCLC.
• To identify the genomic underpinnings of NSCLC heterogeneity and its impact on prognosis.

Main Methods:

• Sequencing of 25 spatially distinct regions from seven operable NSCLC tumors.
• Analysis of copy number alterations, translocations, and mutations, including APOBEC-associated activity.
• Comparative analysis of mutation patterns in tumors from current and former smokers.

Main Results:

• Evidence of branched evolutionary patterns in NSCLC, with driver mutations appearing at different stages.
• Pronounced intratumor heterogeneity in genomic alterations, including copy number changes and translocations.
• Shifts in mutation signatures over time in smokers, with a decrease in smoking-related mutations and an increase in APOBEC-associated mutations.
• Identification of genome-doubling events in former smokers preceding subclonal diversification, suggesting a long latency period.

Conclusions:

• Regionally distinct driver mutations and pervasive genome instability in NSCLC complicate treatment strategies.
• The heterogeneous and dynamic nature of NSCLC evolution presents significant challenges for therapeutic success.
• Understanding these evolutionary dynamics is key to developing more effective treatments for NSCLC.